Empirical use of ciprofloxacin for acute uncomplicated pyelonephritis caused by Escherichia coli in communities where the prevalence of fluoroquinolone resistance is high.
about
Increasing Resistance to Extended-Spectrum Cephalosporins, Fluoroquinolone, and Carbapenem in Gram-Negative Bacilli and the Emergence of Carbapenem Non-Susceptibility in Klebsiella pneumoniae: Analysis of Korean Antimicrobial Resistance Monitoring SVirulence genotype and phylogenetic groups in relation to Chinese herb resistance among Escherichia coli from patients with acute pyelonephritis.Clinical importance and epidemiology of quinolone resistance.Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coliTreatment of complicated urinary tract infections with an emphasis on drug-resistant gram-negative uropathogens.Risk factors that influence the empirical treatment of patients with acute pyelonephritis: a cohort study.The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.In Vivo Bioluminescent Monitoring of Therapeutic Efficacy and Pharmacodynamic Target Assessment of Antofloxacin against Escherichia coli in a Neutropenic Murine Thigh Infection Model.Clinical Practice Guidelines for the Antibiotic Treatment of Community-Acquired Urinary Tract Infections.Summary of the UAA-AAUS guidelines for urinary tract infections.
P2860
Q31164789-2F6F525D-EDC1-4540-89F9-19F5828417E2Q34367387-FCB994CF-E7A1-4DD5-8025-A9CB033D2D3DQ34838791-2AE08D91-C832-4CCA-ABCE-3E167C49D2BFQ36461110-FDCC6DF8-0E1C-4164-B1A9-391C8B59D361Q38078878-BDD33CB6-F2D3-4485-99FB-F94C863848ECQ41991746-3370F26C-8ABA-4E97-97A7-1F3C2106AC8BQ42210504-12EE62F3-3745-4F5C-9857-08FEABF56B0CQ50077307-3BCC3A8A-56B0-4E65-8272-2F4D564C9F16Q53074500-6D9EC2C4-4390-4D7F-A458-5F0832100381Q54307599-780D2929-3A43-41A6-80DF-0FAA31E5D30E
P2860
Empirical use of ciprofloxacin for acute uncomplicated pyelonephritis caused by Escherichia coli in communities where the prevalence of fluoroquinolone resistance is high.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Empirical use of ciprofloxacin ...... oquinolone resistance is high.
@ast
Empirical use of ciprofloxacin ...... oquinolone resistance is high.
@en
type
label
Empirical use of ciprofloxacin ...... oquinolone resistance is high.
@ast
Empirical use of ciprofloxacin ...... oquinolone resistance is high.
@en
prefLabel
Empirical use of ciprofloxacin ...... oquinolone resistance is high.
@ast
Empirical use of ciprofloxacin ...... oquinolone resistance is high.
@en
P2093
P2860
P50
P356
P1476
Empirical use of ciprofloxacin ...... oquinolone resistance is high.
@en
P2093
Eu Suk Kim
Jae Hyun Jeon
Joong Eui Rhee
Kyoung Un Park
Nam Joong Kim
Sang Hoon Song
Woong Dae Han
P2860
P304
P356
10.1128/AAC.06212-11
P407
P577
2012-03-05T00:00:00Z